BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
#5PRI RANKED
Most Cited Paper
in T-cell and B-cell Immunology
18 Months Post-Publication
Class of 2026
“BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial”
A research intelligence initiative by Pepkio
pri.pepkio.com/top-papers/t-cell-and-b-cell-immunology/2026/
Topics
Dual-target CAR T cells · systemic lupus erythematosus · phase 1 clinical trial · BCMA · CD19 · Dual-target CAR T cells · autoimmune disease · B cell depletion · plasma cell targeting · CAR T cell therapy
Share
Cite this ranking
Pepkio Research Index (PRI). Topics and Trends in Most Cited T-cell and B-cell Immunology Papers, Class of 2026. https://pri.pepkio.com/top-papers/t-cell-and-b-cell-immunology/2026. Accessed 2026-07-21. Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459